Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Abroad (travel likely)RecruitingPHASE2
Conditions
Interstitial Lung Disease · Common Variable Immunodeficiency
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California, San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Michele Pham, MD)University of South Florida, Tampa, Florida, United States
Contact: Principal Investigator (Jolan Walter, MD)Lahey Hospital and Medical Center, Burlington, Massachusetts, United States
Contact: Principal Investigator (Jocelyn Farmer, MD)Mayo Clinic, Rochester, Minnesota, United States
Contact: Principal Investigator (Avni Joshi, MD)Duke University Health System, Durham, North Carolina, United States
Contact: Principal Investigator (Peter Bressler, MD)Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Michael Jordan, MD)
Study leads
Michael Jordan
Principal Investigator
Children's Hospital Medical Center, Cincinnati